The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo- controlled treatment with rupatadine 10 and 20 mg

Journal of the European Academy of Dermatology and Venereology

How to Cite

Giménez-Arnau, A., Izquierdo, I. and Maurer, M. (2009), The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo- controlled treatment with rupatadine 10 and 20 mg. Journal of the European Academy of Dermatology and Venereology, 23: 1088–1091. doi: 10.1111/j.1468-3083.2009.03289.x

Author Information

1. ¹

   Servicio de Dermatología, Hospital del Mar, IMAS, Universitat Autònoma de Barcelona, Barcelona, Spain

2. ²

   Department of Clinical Development, J Uriach & Cia, S.A, Barcelona, Spain

3. ³

   Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin, Germany

^* *Correspondence: I Izquierdo. E-mail: clin-izquierdo@uriach.com

Publication History

1. Issue published online: 29 JUL 2009
2. Article first published online: 18 MAY 2009
3. Received: 28 November 2008; Accepted 13 March 2009